Clinical Trial Update: "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk [Phase 3]

View source ↗

Summary

The REDUCE Phase 3 trial sponsored by GlaxoSmithKline has completed and posted results evaluating whether dutasteride can reduce the incidence of prostate cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DUTASTERIDE (Dutasteride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Prostate | Phase 3 | Status: COMPLETED | Results posted: 2010-03-05